Shareholder Votes

QUALYS, INC. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-06-10 meeting.

“The stockholders ratified the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026.”

QUALYS, INC. shareholders approved Election of Class II directors at the 2026-06-10 meeting.

“The stockholders elected each of the following nominees as Class II directors to serve on the Company’s board of directors (the “Board”) until the Company’s 2029 annual meeting of stockholders or until their respective successors are duly elected and qualified.”

Airbnb, Inc. shareholders rejected Stockholder proposal regarding report on risks of politicized divestments. at the 2026-06-05 meeting.

“The Company’s stockholders did not approve a stockholder proposal regarding reporting on risks of politicized divestments.”

Airbnb, Inc. shareholders rejected Stockholder proposal regarding dual-class sunset. at the 2026-06-05 meeting.

“The Company’s stockholders did not approve a stockholder proposal regarding a dual-class sunset.”

Airbnb, Inc. shareholders rejected Stockholder proposal regarding report on discrimination in charitable support. at the 2026-06-05 meeting.

“The Company’s stockholders did not approve a stockholder proposal regarding reporting on discrimination in charitable support.”

Airbnb, Inc. shareholders rejected Stockholder proposal regarding oversight of risks relating to digital services. at the 2026-06-05 meeting.

“The Company’s stockholders did not approve a stockholder proposal regarding oversight of risks relating to digital services.”

Airbnb, Inc. shareholders approved Advisory vote on the approval of the compensation of the Company’s named executive officers for fiscal year ended December 31, 2025. at the 2026-06-05 meeting.

“The Company’s stockholders approved, on an advisory (non-binding) basis, the compensation of the Company's named executive officers for the fiscal year ended December 31, 2025, as disclosed in the Company's proxy statement for the Annual Meeting pursuant to the compensation disclosure rules of the Securities and Exchange Commission.”

Airbnb, Inc. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026. at the 2026-06-05 meeting.

“The Company’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

Airbnb, Inc. shareholders approved Election of Nathan Blecharczyk, Alfred Lin and James Manyika as Class III directors for a three-year term. at the 2026-06-05 meeting.

“The Company’s stockholders elected Nathan Blecharczyk, Alfred Lin and James Manyika as members of the Company’s board of directors as Class III directors for a three-year term.”

Tvardi Therapeutics, Inc. shareholders approved Ratification of the Selection of Independent Registered Public Accounting Firm at the 2026-06-09 meeting.

“The stockholders ratified the selection by the Audit Committee of the Board of Directors of the Company of Deloitte & Touche LLP”

Tvardi Therapeutics, Inc. shareholders approved Advisory Vote on the Frequency of Solicitation of Advisory Stockholder Approval of Executive Compensation at the 2026-06-09 meeting.

“3,513,039 147,472 Cynthia Smith 3,392,877 267,634 Sujal Shah 3,507,652 152,859 Broker Non-Votes: 2,975,429 Proposal 2 – Non-Binding, Advisory Vote on Executive Compensation The stockholders approved,”

Tvardi Therapeutics, Inc. shareholders approved Non-Binding, Advisory Vote on Executive Compensation at the 2026-06-09 meeting.

“The stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers, by the following votes: Votes For Votes Against Abstentions Broker Non-Votes 3,482,265 161,795 16,451 2,975,429”

Tvardi Therapeutics, Inc. shareholders approved Election of Directors at the 2026-06-09 meeting.

“Imran Alibhai, Ph.D., Cynthia Smith and Sujal Shah were each elected to serve as a Class II director of the Company’s Board of Directors until the 2029 Annual Meeting of Stockholders”

TELA Bio, Inc. shareholders approved Approval of an amendment to the TELA Bio, Inc. Amended and Restated 2019 Equity Incentive Plan to, among other things, increase the authorized shares issuable thereunder by 3,500,000 shares. at the 2026-04-24 meeting.

“Proposal 4 - Approval of an amendment to the TELA Bio, Inc. Amended and Restated 2019 Equity Incentive Plan to, among other things, increase the authorized shares issuable thereunder by 3,500,000 shares. The Plan Amendment was approved, as follows: Votes For Votes Against Abstentions Broker Non-Votes 27,256,266 538,830 16,593 5,650,509”

TELA Bio, Inc. shareholders approved Approval, on a non-binding advisory basis, of the compensation of the Company’s named executive officers. at the 2026-04-24 meeting.

“Proposal 3 - Approval, on a non-binding advisory basis, of the compensation of the Company’s named executive officers. The stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers, as follows: Votes For Votes Against Abstentions Broker Non-Votes 20,891,695 6,900,032 19,962 5,650,509”

TELA Bio, Inc. shareholders approved Election of Class I Directors at the 2026-04-24 meeting.

“Proposal 1 - Election of Class I Directors . Each of Joseph Capper, Betty Jo Rocchio and William Plovanic were elected to the Board to serve as Class I directors until the 2029 Annual Meeting of Stockholders and until their successors, if any, are elected or appointed, or their earlier death, resignation, retirement, disqualification or removal, as follows: Name For Withheld Broker Non-Votes Joseph Capper 27,244,482 567,207 5,650,509 Betty Jo Rocchio 27,595,955 215,734 5,650,509 William Plovanic 27,497,453 314,236 5,650,509”

Carlyle Secured Lending, Inc. shareholders approved Ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-09 meeting.

“Proposal 2. The ratification of the selection of EY as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026: For Against Abstain Broker Non-Votes 40,207,883 443,413 688,343 —”

Carlyle Secured Lending, Inc. shareholders approved Election of each of Linda Pace and William H. Wright II as Class I directors for a three-year term at the 2026-06-09 meeting.

“Proposal 1. The election of each of Linda Pace and William H. Wright II, each to serve as a Class I director for a three-year term, in each case until their successor is duly elected and qualified or their earlier death, resignation or removal: Nominees For Withhold Broker Non-Votes Linda Pace 19,608,442 1,551,759 20,179,438 William H. Wright II 14,713,660 6,446,541 20,179,438”

Freshpet, Inc. shareholders approved Non-Binding Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers at the 2026-06-10 meeting.

“The executive compensation of the Company’s named executive officers was approved with the following non-binding advisory votes: FOR AGAINST ABSTAIN 40,844,496 1,682,726 51,281”

Freshpet, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-10 meeting.

“The appointment of KPMG LLP as the Company’s independent registered public accounting firm for 2026 was ratified with the following votes: FOR AGAINST ABSTAIN 44,890,659 115,995 47,158”

Freshpet, Inc. shareholders approved Election of Directors at the 2026-06-10 meeting.

“All nominees were elected to serve on the Board of Directors pursuant to the following votes: DIRECTOR FOR AGAINST ABSTAIN Olu Beck 42,454,032 73,236 51,235”

CATERPILLAR INC shareholders rejected Shareholder Right to Act by Written Consent at the 2026-06-10 meeting.

“Proposal 4 - Shareholder Proposal - Shareholder Right to Act by Written Consent The proposal requesting that the Board of Directors amend the Company's governing documents to permit shareholder action by written consent was not approved based on the following vote: For Against Abstain Broker Non-Votes 127,707,438 195,268,191 2,477,721 68,032,649”

CATERPILLAR INC shareholders approved Advisory Vote to Approve Executive Compensation at the 2026-06-10 meeting.

“Proposal 3 - Company Proposal - Advisory Vote to Approve Executive Compensation The proposal requesting that the shareholders of the Company approve executive compensation, on an advisory basis, was approved with the following vote: For Against Abstain Broker Non-Votes 307,919,503 15,792,946 1,740,901 68,032,649”

CATERPILLAR INC shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2026-06-10 meeting.

“Proposal 2 - Company Proposal - Ratification of Independent Registered Public Accounting Firm The proposal requesting ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2026 was approved with the following vote: For Against Abstain 372,882,425 19,911,190 692,384”

CATERPILLAR INC shareholders approved Election of Directors at the 2026-06-10 meeting.

“Proposal 1 - Company Proposal - Election of Directors All nominees for election to the Company’s Board of Directors named in the Proxy Statement were elected, each to a one-year term, with the following vote: Director For Against Abstain Broker Non-Votes Joseph E. Creed 313,113,033 11,832,714 507,603 68,032,649 James C. Fish, Jr. 308,288,837 16,538,220 626,293 68,032,649 Lynn J. Good 323,118,292 1,773,531 561,527 68,032,649 Gerald Johnson 320,479,013 4,353,437 620,900 68,032,649 Nazzic S. Keene 321,589,855 3,001,338 862,157 68,032,649 David W. MacLennan 316,380,421 8,437,215 635,714 68,032,649 Judith F. Marks 320,418,944 4,488,540 545,866 68,032,649 Debra L. Reed-Klages 316,254,559 8,655,657 543,134 68,032,649 Susan C. Schwab 315,235,222 9,709,139 508,989 68,032,649 Rayford Wilkins, Jr. 315,044,827 9,550,171 858,352 68,032,649”

Bolt Biotherapeutics, Inc. shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for 2026 at the 2026-06-10 meeting.

“The selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 was ratified.”

Bolt Biotherapeutics, Inc. shareholders approved Election of Class II directors at the 2026-06-10 meeting.

“The following director nominees were elected to serve as Class II members of the Company’s board of directors until the Company’s 2029 Annual Meeting of Stockholders, or until their respective successor is duly elected and qualified, or until their respective death, resignation or removal:”

Marqeta, Inc. shareholders approved Non-binding advisory vote on the compensation paid to named executive officers at the 2026-06-10 meeting.

“Proposal 5 : Holders of the Company’s Class A and Class B common stock voted to approve, on a non-binding advisory basis, the compensation paid to the Company’s named executive officers. The final voting results are as follows: For: 389,625,862 Against: 106,659,393 Abstain: 1,041,334 Broker Non-Votes: 78,811,104”

Marqeta, Inc. shareholders approved Amendment to Amended and Restated Certificate of Incorporation to provide for officer exculpation as permitted by Delaware law at the 2026-06-10 meeting.

“Proposal 4 : Holders of the Company’s Class A and Class B common stock voted to approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide for officer exculpation as permitted by Delaware law. The final voting results are as follows: For: 391,167,767 Against: 105,868,988 Abstain: 289,834 Broker Non-Votes: 78,811,104”

Marqeta, Inc. shareholders approved Amendment to Amended and Restated Certificate of Incorporation to effect a 1-for-4 reverse stock split and related reduction of authorized Common Stock and Preferred Stock at the 2026-06-10 meeting.

“Proposal 3 : Holders of the Company’s Class A and Class B common stock voted to approve an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a 1-for-4 reverse stock split and related reduction of the Company's authorized Common Stock and Preferred Stock. There were no broker non-votes on this proposal. The final voting results are as follows: For: 556,674,402 Against: 19,097,624 Abstain: 365,667”

Marqeta, Inc. shareholders approved Ratify the selection of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-10 meeting.

“Proposal 2 : Holders of the Company’s Class A and Class B common stock voted to ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. There were no broker non-votes on this proposal. The final voting results are as follows: For: 574,083,887 Against: 1,562,679 Abstain: 491,127”

Marqeta, Inc. shareholders approved Election of four Class II director nominees at the 2026-06-10 meeting.

“Proposal 1 : Holders of the Company’s Class A and Class B common stock voted to elect the four Class II director nominees to the Company’s Board of Directors, each to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified or until such director’s earlier death, resignation, or removal. The final voting results are as follows: Nominee For Withheld Broker Non-Votes Najuma Atkinson 436,680,233 60,646,356 78,811,104 Martha Cummings 408,511,946 88,814,643 78,811,104 Judson (Jud) Linville 458,659,825 38,666,764 78,811,104 Michael (Mike) Milotich 494,797,547 2,529,042 78,811,104”

Design Therapeutics, Inc. shareholders approved Ratification of Selection of Independent Registered Public Accounting Firm at the 2026-06-09 meeting.

“Proposal 2. Ratification of Selection of Independent Registered Public Accounting Firm The Company’s stockholders ratified the selection by the Audit Committee of the Company’s Board of Directors of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The final voting results are as follows: Votes For Votes Against Abstentions Broker Non-Votes 50,077,708 201 906 Not applicable”

Design Therapeutics, Inc. shareholders approved Election of Director at the 2026-06-09 meeting.

“Proposal 1. Election of Director The Company’s stockholders elected the one person listed below as a Class II director, to serve until the Company’s 2029 Annual Meeting of Stockholders and until his successor is duly elected and qualified, or, if sooner, until his death, resignation or removal. The final voting results are as follows: Votes For Votes Withheld Broker Non-Votes Simeon George, M.D. 29,205,208 7,608,724 13,264,883”

FLAGSTAR BANK, NATIONAL ASSOCIATION shareholders approved Approval of amendment to Flagstar Bank, N.A. 2020 Omnibus Incentive Plan to increase shares reserved by 12,000,000 at the 2026-06-09 meeting.

“The results of the vote to approve the Incentive Plan Amendment to the Flagstar Bank, N.A. 2020 Omnibus Incentive Plan were as follows: Shares Voted For Shares Voted Against Abstentions 274,608,504 48,478,199 1,626,879 There were 49,476,445 broker non-votes on this proposal.”

FLAGSTAR BANK, NATIONAL ASSOCIATION shareholders approved Non-binding advisory vote to approve the compensation of the Bank's named executive officers at the 2026-06-09 meeting.

“The results of the vote to approve, on a non-binding advisory basis, the compensation of the Bank’s named executive officers were as follows: Shares Voted For Shares Voted Against Abstentions 262,444,105 60,772,773 1,496,704 There were 49,476,445 broker non-votes on this proposal.”

FLAGSTAR BANK, NATIONAL ASSOCIATION shareholders approved Ratification of appointment of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-09 meeting.

“The appointment of KPMG LLP as the independent registered public accounting firm of the Bank for the fiscal year ending December 31, 2026, was ratified by the following vote: Shares Voted For Shares Voted Against Abstentions 369,716,004 3,581,585 892,438 There were 0 broker non-votes on this proposal.”

FLAGSTAR BANK, NATIONAL ASSOCIATION shareholders approved Election of Directors at the 2026-06-09 meeting.

“The following individuals were elected as directors, each for a one-year term, by the following vote: Name Shares Voted For Shares Voted Against Abstentions Milton Berlinski 317,274,695 6,539,740 899,147 Alan Frank 320,866,496 2,975,197 871,889 Marshall Lux 317,277,171 6,554,116 882,295 Eli H. Miller 321,380,715 2,463,785 869,082 Steven T. Mnuchin 311,080,540 12,803,427 829,615 Joseph Otting 320,823,418 3,026,823 863,341 Allen C. Puwalski 321,353,297 2,490,765 869,520 Jennifer R. Whip 320,377,273 3,505,434 830,875 There were 49,476,445 broker non-votes on this proposal.”

Savers Value Village, Inc. shareholders approved Advisory vote on executive compensation at the 2026-06-10 meeting.

“Votes For Votes Against Abstentions Broker Non-Votes 147,187,839 1,124,301 394,004 2,786,862”

Savers Value Village, Inc. shareholders approved Ratification of KPMG LLP as independent registered public accounting firm at the 2026-06-10 meeting.

“Votes For Votes Against Abstentions Broker Non-Votes 150,947,679 376,879 168,448 0”

Savers Value Village, Inc. shareholders approved Election of Class III directors at the 2026-06-10 meeting.

“Nominee Votes For Votes Withheld Broker Non-Votes Aina E. Konold 147,280,590 1,425,554 2,786,862 Kristy Pipes 141,736,189 6,969,955 2,786,862 Brian Ames 135,907,168 12,798,976 2,786,862”

Carlyle Credit Solutions, Inc. shareholders approved Ratification of selection of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-09 meeting.

“For Against Abstain Broker Non-Votes 54,861,655 24,072 28,055 —”

Carlyle Credit Solutions, Inc. shareholders approved Election of Class I directors Linda Pace and William H. Wright II at the 2026-06-09 meeting.

“Nominees For Withhold Broker Non-Votes Linda Pace 54,748,582 165,200 — William H. Wright II 54,756,596 157,186 —”

BLACKBAUD INC shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-10 meeting.

“Stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 as follows: Votes Cast For 43,066,803 Votes Cast Against 16,254 Abstentions 61,234 Broker Non-Votes N/A”

BLACKBAUD INC shareholders approved Vote to Approve the Amendment and Restatement of the Blackbaud, Inc. 2016 Equity and Incentive Compensation Plan at the 2026-06-10 meeting.

“Stockholders approved the amendment and restatement of the Blackbaud, Inc. 2016 Equity and Incentive Compensation Plan as follows: Votes Cast For 30,347,408 Votes Cast Against 996,738 Abstentions 30,135 Broker Non-Votes 11,770,010”

BLACKBAUD INC shareholders approved Advisory Vote to Approve Named Executive Officer Compensation at the 2026-06-10 meeting.

“Stockholders approved on an advisory basis the 2025 compensation of the Company’s named executive officers as follows: Votes Cast For 30,822,300 Votes Cast Against 519,936 Abstentions 32,045 Broker Non-Votes 11,770,010”

ALX ONCOLOGY HOLDINGS INC shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-06-10 meeting.

“Proposal 3: Ratification of the Appointment of Independent Registered Public Accounting Firm For Against Abstain 119,293,775 1,797 9,292”

ALX ONCOLOGY HOLDINGS INC shareholders approved Advisory Vote on the Compensation of the Company's Named Executive Officers at the 2026-06-10 meeting.

“Proposal 2: Advisory Vote on the Compensation of the Company’s Named Executive Officers For Against Abstain Broker Non-Votes 84,540,061 13,497,711 2,953,259 18,313,833”

ALX ONCOLOGY HOLDINGS INC shareholders approved Election of Two Class II Directors at the 2026-06-10 meeting.

“Proposal 1: Election of Two Class II Directors Name of Director For Withheld Broker Non-Votes Daniel Curran, M.D. 100,933,233 57,798 18,313,833 Rekha Hemrajani 82,732,430 18,258,601 18,313,833 Chris Takimoto, M.D., Ph.D., F.A.C.P. 100,946,696 44,335 18,313,833”

Monte Rosa Therapeutics, Inc. shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-11 meeting.

“The stockholders of the Company ratified the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”